On Demand Webinars
Considerations for mRNA-LNP Potency Assay Development for Gene Editing Products
Presented by Benjamin Hall, Associate Director in Analytical Development at Tessera Therapeutics, Gargi Chaudhuri, Ph.D., Senior Field Applications Scientist, Bio-Techne (Protein Simple)
12th March 2026
Expanding Continuous Manufacturing at Pfizer, Enabling High Drug Load Formulations via Wet Granulation Technology
Presented by Travis Powell, Senior Principal Scientist at Pfizer
10th March 2026
Addressing Subvisible Silicone Oil Droplets-Industry Challenges, Analytical Strategies, and USP’s Rationale for a New General Informational Chapter
Presented by Desmond G Hunt, Senior Principal Scientist at US Pharmacopeia, Laura A. Philips, PhD, MBA President and Chief Executive Officer Spheryx, Inc., Tyler Carter, PhD. Senior Application Scientist, at Yokogawa Fluid Imaging Technologies Inc
04th March 2026
Developing a Site-Wide Contamination Control Strategy: From Risk Mapping to Implementation
Presented by Joseph Horvath, PhD, Head of Quality Risk Management at Takeda Pharmaceuticals, Liz Brockson, Aseptic Processing and Sterility Assurance Lead in Global Sterility Assurance and Microbiology at Takeda
02nd March 2026
mRNA Products: An Overview on Strategy for Potency for DS vs DP
Presented by Khaled Yamout, Analytical Sciences, Quality and Manufacturing Consultant, Yamout Chem Consulting, LLC
24th February 2026
Fatty Acid Extractables/Leachables Profiles as an Indicator of Technical Grade Stearate Acid Additive Origin
Presented by Daniel Norwood, Principal Consultant at Feinberg Norwood & Associates Pharma Consulting
18th February 2026
Enabling Broader Adoption of MAM: Comparison of MAM vs. Conventional Methods
Presented by Diane McCarthy, Senior Director, Science and Standards, Global Biologics Department at US Pharmacopeia, Andrew W. Dawdy, Ph.D. Senior Principal Scientist at Pfizer, Michelle English, Ph.D., Scientific Consultant at Genedata, Ying Qing Yu, PhD, Director of the Biopharmaceutical Applications Team at Waters Corporation
05th February 2026
N-Nitrosamines – Past, Present and Future Through the Eyes of an Analytical Chemist
Presented by Andrew Teasdale, Principal Consultant Nelson Labs
03rd February 2026
Overview and Future Plans of the USP Rapid Microbiological Methods Subcommittee
Presented by Dr David Roesti, PhD. Microbiologist/Facilitator QA/QC at Novartis Pharma AG and Jon Kallay, Senior Technical & Market Development Manager at Charles River Laboratories
29th January 2026
Developing and Deploying Digital & AI Solutions in Pharma: The Reality vs. the Hype
Presented by Saly Romero-Torres, Ph.D. Owner, Hyperplane LLC, Dan Hill, Director, Process Analytics at Fujufilm Biotechnologies, Paul Gillham, Innovations Director, SciY, Ashley Howard, Sr. Director, Product Management A&D at Cytiva and Dr. Alessandro Butté, CEO DataHow
21st January 2026
